Max Healthcare Institute · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
NOA facility, acquired in October-November 2024 from liquidation, required reapplication for all licenses including transplant and blood bank licenses. Equipment ordered from overseas has 6-month delivery lead times. Management acknowledges first quarter is always weakest for new acquisitions.
New units have lower ARPOB than existing hospitals, bringing down network-wide ARPOB growth from 7% (existing units) to flat on reported basis. Management expects this dynamic to persist as more tier-2/3 facilities are added.
Max Nagpur awaiting formal environmental clearance (though civil contract awarded, 24-month completion timeline). Max Vikram Sake awaiting forest department clearance for tree transplantation. Both delays could impact commissioning timelines.
An analyst's attempt to reconcile ARPOB growth figures across hospital cohorts was challenged by management, who stated the analyst's formula was incorrect and that occupied bed days had increased, not decreased. Management requested offline follow-up, suggesting potential complexity in understanding the cohort-level metrics.
